Solid Biosciences Inc.’s SLDB share price has dipped by 14.97%, which has investors questioning if this is right time to buy.

Kyle Bryant was diagnosed with Friedreich's Ataxia, or FA, at 17 years old. Friedreich's Ataxia is a a rare neuromuscular disease that affects 1 in 50,000 people. Over the last ...

FDA stated in written correspondence for a START pilot program meeting that it is open to considering skin FXN concentration ...

NEW YORK, March 24, 2025 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine ...

Larimar Therapeutics, Inc.’s LRMR share price has dipped by 10.24%, which has investors questioning if this is right time to ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the ...

As the only approved treatment to address disease progression, SKYCLARYS addresses a long-standing gap in the care of Canadians living with Friedreich's ataxia Friedreich's ataxia is a rare ...

If you’re feeling the rumblings of change, trust the journey that's about to unfold The first eclipse of 2025 is approaching! If you’re familiar with the effects of this astronomical ...

Here's what's in store for your zodiac sign with the arrival of March's full moon on March 13, which will double as a total lunar eclipse and a blood moon Skyler Caruso is a Writer and Reporter of ...